Can-Fite BioPharma Ltd. Quarterly Common Stock, Par or Stated Value Per Share in ILS/shares from Q4 2013 to Q1 2023

Taxonomy & unit
us-gaap: ILS/shares
Description
Face amount or stated value per share of common stock.
Summary
Can-Fite BioPharma Ltd. quarterly Common Stock, Par or Stated Value Per Share history and growth rate from Q4 2013 to Q1 2023.
  • Can-Fite BioPharma Ltd. Common Stock, Par or Stated Value Per Share for the quarter ending February 22, 2023 was 0.25 ILS/shares.
Common Stock, Par or Stated Value Per Share, Quarterly (ILS/shares)
Common Stock, Par or Stated Value Per Share, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 0.25 Feb 22, 2023 20-F 2024-03-28
Q2 2022 0.25 0 0% Jun 30, 2022 6-K 2022-08-25
Q4 2021 0.25 0 0% Dec 31, 2021 6-K 2022-08-25
Q2 2021 0.25 Jun 30, 2021 6-K 2021-08-26
Q4 2020 0.25 0 0% Dec 31, 2020 20-F 2022-03-24
Q1 2020 5B* Apr 28, 2020 20-F 2023-03-30
Q4 2019 0.25 Dec 31, 2019 20-F 2021-03-25
Q4 2013 0.25 Nov 28, 2013 20-F 2022-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.